Marina Payeras

  • Citations Per Year
Learn More
BACKGROUND/AIMS Insulin-like growth factor I (IGF-I) is an anabolic hormone synthesized in the liver whose levels decrease sharply in liver cirrhosis. METHODS We conducted a randomized double-blind placebo-controlled clinical trial to evaluate the effect of subcutaneous administration of IGF-I (20 microg/kg/day with dose escalation to 50-100(More)
This paper presents an academic initiative to increase the motivation of students for engineering topics, and discusses the results obtained. The initiative is a journal where students may publish, both in paper and in electronic format, the final reports of their laboratory works or research activities. The name of the journal is enginy@eps. The existence(More)
OBJECTIVE Hypermetabolism in cirrhosis is associated with a high risk of complications and mortality. However, studies about underlying mechanisms are usually focussed on isolated potential determinants and specific etiologies, with contradictory results. We aimed at investigating differences in nutrition, metabolic hormones, and hepatic function between(More)
  • 1